Our approach to treating a patient with a vein of Galen aneurysm is, of course, influenced greatly by the age of the patient, the clinical symptoms, and the angiographic architecture of the malformation. Therapeutic options are primarily based on whether a true AVM is present or if the malformation represents an arteriovenous fistula involving the vein of Galen. Arterial endovascular approaches...

Purpose Adjuvant coils may offer advantages in flow control during glue embolization of high flow vein of Galen aneurysmal malformation (VGAM) patients but involves specific issues such as feasibility, durability and coil mass effect. The purpose of this study is to assess the outcome of adjuvant coils in addition to transarterial glue embolization for treatment of these patients. Materials a...

The Doctrine of Final Cause, taken from Aristotle's "causes" and modified by Claudius (Aelius) Galen (of Pergamon) stated that for an anatomical part to exist it must have a "cause," not an end point, but a purpose or goal, natural or divine. This affected the renaissance anatomist's thinking. We explore this doctrine's relationship with human head and neck anatomy from antiquity's Aristotle an...

Published reports and personal experience are reviewed relating to patients under 1 year of age diagnosed with a vein of Galen malformation and congenital heart disease. Including five patients from this institution, a total of 23 patients (12 neonates) with congenital heart disease and a vein of Galen malformation have been reported. Six of these had sinus venosus atrial septal defect and nine...

Vein of Galen malformations are unique congenital malformations of the cerebral vasculature that result in persistence and 'aneurysmal' dilatation of the venous structures. The varied clinical presentations and their distinctive and complex angioarchitecture make it important for the caring physician to understand their embryological and pathophysiological aspects. Management of these lesions--...

Doctor Honoris Causa because of his international contribution to and development of Quantitative Pathology. The official ceremony took place on 26 May 2000 in the Aula Magna of the University of Antwerp.